Stock Earnings

Question 1

Quels sont les états financiers clés de EyePoint Pharmaceuticals Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), EyePoint Pharmaceuticals Inc a un total d'actifs de $418, un bénéfice net loss de $-130

Question 2

Quels sont les ratios financiers clés pour EYPT ?

Accepted Answer

Le ratio de liquidité de EyePoint Pharmaceuticals Inc est 5.16, la marge nette est -302.32, les ventes par action sont de $0.76.

Question 3

Comment les revenus de EyePoint Pharmaceuticals Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

EyePoint Pharmaceuticals Inc largest revenue segment is Ophthalmic Products, at a revenue of 43,273,000 in the most earnings release.For geography, United States is the primary market for EyePoint Pharmaceuticals Inc, at a revenue of 42,049,000.

Question 4

EyePoint Pharmaceuticals Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, EyePoint Pharmaceuticals Inc a un bénéfice net loss de $-130

Question 5

EyePoint Pharmaceuticals Inc a-t-elle des passifs ?

Accepted Answer

yes, EyePoint Pharmaceuticals Inc a un passif de 81

Question 6

Combien d'actions en circulation EyePoint Pharmaceuticals Inc a-t-elle ?

Accepted Answer

EyePoint Pharmaceuticals Inc a un total d'actions en circulation de 68.26

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	51	43	46	41	36	34
Revenue Growth (YoY)	2%	-7%	12%	14%	6%	70%
Cost of Revenue	2	3	4	8	8	5
Gross Profit	49	39	41	33	28	28
Selling, General & Admin	55	55	51	60	53	45
Research & Development	183	130	64	49	28	17
Operating Expenses	238	185	116	112	84	65
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-175	-130	-70	-102	-58	-45
Income Tax Expense	0	0	0	--	--	--
Net Income	-175	-130	-70	-102	-58	-45
Net Income Growth	103%	86%	-31%	76%	28.99%	-20%
Shares Outstanding (Diluted)	69.92	56.29	38.9	37.32	28.76	12.84
Shares Change (YoY)	31%	45%	4%	30%	124%	23%
EPS (Diluted)	-2.5	-2.32	-1.81	-2.74	-2.03	-3.54
EPS Growth	53%	28%	-34%	35%	-43%	-35%
Free Cash Flow	-194	-130	-1	-67	-50	-14
Free Cash Flow Per Share	-2.77	-2.3	-0.02	-1.79	-1.73	-1.09
Gross Margin	96.07%	90.69%	89.13%	80.48%	77.77%	82.35%
Operating Margin	-370.58%	-337.2%	-163.04%	-190.24%	-152.77%	-105.88%
Profit Margin	-343.13%	-302.32%	-152.17%	-248.78%	-161.11%	-132.35%
Free Cash Flow Margin	-380.39%	-302.32%	-2.17%	-163.41%	-138.88%	-41.17%
EBITDA	-188	-144	-75	-76	-53	-34
EBITDA Margin	-368.62%	-334.88%	-163.04%	-185.36%	-147.22%	-100%
D&A For EBITDA	1	1	0	2	2	2
EBIT	-189	-145	-75	-78	-55	-36
EBIT Margin	-370.58%	-337.2%	-163.04%	-190.24%	-152.77%	-105.88%
Effective Tax Rate	0%	0%	0%	--	--	--

EyePoint Pharmaceuticals Inc (EYPT) Price

EYPT Stock Price Chart

EYPT Income

Follow-Up Questions